Clinical Trial

Citadel Embolization Device Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to gather safety and effectiveness data on Stryker Neurovascular's Next Generation Target Detachable Coil (hereafter referred to as the Citadel Embolization Device), when used with Target Detachable Coils, in the treatment of wide-neck intracranial aneurysms.
Protocol Amendment History 18 amendments
This ClinicalTrials.gov record has been amended 18 times since 2019-08-12; most recent amendment 2026-03-25.
Status change: Recruiting → Active, Not Recruiting 2025-08-20
Status change: Enrolling by Invitation → Recruiting 2023-06-14
Trial Details
NCT Number NCT04057352
Lead Sponsor Stryker Neurovascular
Conditions Unruptured Wide-neck Aneurysms
Enrollment 150 participants
Start Date 2019-07-18
Primary Completion 2026-11-15 (estimated)
Study Completion 2026-11-15 (estimated)
Updated on ClinicalTrials.gov 2026-03-30